26 - Infectious Diseases and Incarcerated Persons

Thursday, October 20, 2022

10:30 AM – 11:45 AM US ET

Location: 150 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Emily Erbelding, MD

Director, Division of Microbiology and Infectious Disease NIAID
National Institutes of Health
Rockville, MD, United States

Disclosure(s): No financial relationships to disclose
Newton Kendig, MD

Clinical Professor of Medicine
The George Washington University
Washington, DC, United States

Disclosure(s): VitalCore Health Strategies: Advisor/Consultant (Ongoing)

Slides

Faculty(s)

Liesl Hagan, MPH

Senior Scientist for Correctional Health
Centers for Disease Control and Prevention
Atlanta, United States

Disclosure(s): No financial relationships to disclose

Slides
Lara Strick, MD, MS (she/her/hers)

Infectious Disease Physician
University of Washington

Disclosure(s): No financial relationships to disclose

Slides
Anne Spaulding, MD, MPH

Associate Professor
Emory University
Atlanta, GA, United States

Disclosure(s): Gilead Science: Grant/Research Support (Terminated)

Slides

Disclosure(s):

Emily Erbelding, MD: No financial relationships to disclose

Newton Kendig, MD: VitalCore Health Strategies: Advisor/Consultant (Ongoing)

Liesl Hagan, MPH: No financial relationships to disclose

Lara B. Strick, MD, MS: No financial relationships to disclose

Anne C. Spaulding, MD, MPH: Gilead Science: Grant/Research Support (Terminated)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe best practices for STI screening and treatment in the incarcerated setting;
summarize approaches to prevention of COVID in correctional settings;
identify features of successful HCV treatment in prisons

Presentations:

10:30 AM – 10:55 AM US ET

Addressing COVID-19 in the Correctional Setting
Speaker: Liesl Hagan, MPH – Centers for Disease Control and Prevention
10:55 AM – 11:20 AM US ET

Prison-Based Programs to Identify and Treat HCV
Speaker: Lara B. Strick, MD, MS (she/her/hers) – University of Washington
11:20 AM – 11:45 AM US ET

Best Practices for STI Screening and Treatment in Persons Who Are Incarcerated
Speaker: Anne C. Spaulding, MD, MPH – Emory University